Larede, Liberato B.
HRN: 23-49-69 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/12/2023
08/19/2023
IVT
600mg
Q6
Dm Foot; Cellulitis Left Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes